Mutation analysis of the muscarinic cholinergic receptor genes in isolated growth hormone deficiency type IB

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 7, 2009, Pages 2565-2570

  Mohamadi, Ali ^a   Martari, Marco ^a   Holladay, Cindy D ^b   Phillips III, John A ^b   Mullis, Primus E ^c   Salvatori, Roberto ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ISOLEUCINE; MESSENGER RNA; METHACHOLINE; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC M4 RECEPTOR; MUSCARINIC M5 RECEPTOR; VALINE;

ANIMAL CELL; ARTICLE; CHO CELL; CODON; CONTROLLED STUDY; FAMILY; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC CODE; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HOMOZYGOSITY; HUMAN; HYPOTHALAMUS; NONHUMAN; PRIORITY JOURNAL; RECEPTOR GENE; SIGNAL TRANSDUCTION;

ANIMALIA; MUS MUSCULUS;

EID: 67650248717     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-0512     Document Type: Article

References (41)

1. Moseley CT, Mullis PE, Prince MA, Phillips 3rd JA 2002 An exon splice enhancer mutation causes autosomal dominant GH deficiency. J Clin Endocrinol Metab 87:847-852
2. Lindsay R, Feldkamp M, Harris D, Robertson J, Rallison M 1994 Utah growth study: growth standards and the prevalence of growth hormone deficiency. J Pediatr 125:29-35
3. Salvatori R 2004 Growth hormone and IGF-1. Rev Endocr Metab Disord 5:15-23
4. Mullis PE 2005 Genetic control of growth. Eur J Endocrinol 152:11-31
5. Salvatori R, Fan X, Phillips 3rd JA, Espigares-Martin R, Martin De Lara I, Freeman KL, Plotnick L, Al-Ashwal A, Levine MA 2001 Three new mutations in the gene for the growth hormone (GH)-releasing hormone receptor in familial isolated GH deficiency type IB. J Clin Endocrinol Metab 86:273-279
6. Wagner JK, Eblé A, Hindmarsh PC, Mullis PE 1998 Prevalence of human GH-1 gene alterations in patients with isolated growth hormone deficiency. Pediatr Res 43:105-110
7. Dieguez C, Page MD, Peters JR, Scanlon MF 1988 Growth hormone and its modulation. J R Coll Physicians Lond 22:84-91
8. Friend K, Iranmanesh A, Login IS, Veldhuis JD 1997 Pyridostigmine treatment selectively amplifies the mass of GH secreted per burst without altering GH burst frequency, half-life, basal GH secretion or the orderliness of GH release. Eur J Endocrinol 137:377-386
9. Coiro V, Volpi R, Capretti L, Giuliani N, Caffarri G, Colla R, Marchesi C, Chiodera P 1998 Different effects of naloxone on the growth hormone response to melatonin and pyridostigmine in normal men. Metabolism 47:814-816
10. Massara F, Ghigo E, Molinatti P, Mazza E, Locatelli V, Muller EE, Camanni F 1986 Potentiation of cholinergic tone by pyridostigmine bromide re-instates and potentiates the growth hormone responsiveness to intermittent administration of growth hormone-releasing factor in man. Acta Endocrinol (Copenh) 113:12-16
11. Peñalva A, Muruais C, Casanueva FF, Dieguez C 1990 Effect of enhancement of endogenous cholinergic tone with pyridostigmine on the dose-response relationships of growth hormone (GH)-releasing hormone-induced GH secretion in normal subjects. J Clin Endocrinol Metab 70:324-327
12. Kelijman M, Frohman LA 1991 The role of the cholinergic pathway in growth hormone feedback. J Clin Endocrinol Metab 72:1081-1087
13. Arvat E, Cappa M, Casanueva FF, Dieguez C, Ghigo E, Nicolosi M, Valcavi R, Zini M 1993 Pyridostigmine potentiates growth hormone (GH)-releasing hormone-induced GH release in both men and women. J Clin Endocrinol Metab 76:374-377
14. Arvat E, Gianotti L, Ragusa L, Valetto MR, Cappa M, Aimaretti G, Ramunni J, Grottoli S, Camanni F, Ghigo E 1996 The enhancing effect of pyridostigmine on the GH response to GHRH undergoes an accelerated age-related reduction in Down syndrome. Dementia 7:288-292
15. Delitala G, Frulio T, Pacifico A, Maioli M 1982 Participation of cholinergic muscarinic receptors in glucagon- and arginine-mediated growth hormone secretion in man. J Clin Endocrinol Metab 55:1231-1233
16. Massara F, Ghigo E, Goffi S, Molinatti GM, Müller EE, Camanni F 1984 Blockade of hp-GRF-40-induced GH release in normal men by a cholinergic muscarinic antagonist. J Clin Endocrinol Metab 59:1025-1026
17. Valcavi R, Dieguez C, Zini M, Page MD, Dotti C, Portioli I, Scanlon MF 1991 Effect of pyridostigmine and pirenzepine on GH responses to GHRH in hyperthyroid patients. Clin Endocrinol (Oxf) 35:141-144
18. Fedi M, Bach LA, Berkovic SF, Willoughby JO, Scheffer IE, Reutens DC 2008 Association of a nicotinic receptor mutation with reduced height and blunted physostigmine-stimulated growth hormone release. J Clin Endocrinol Metab 93:634-637
19. Wess J, Eglen RM, Gautam D 2007 Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development. Nat Rev Drug Discov 6:721-733
20. Gautam D, Jeon J, Starost MF, Han SJ, Hamdan FF, Cui Y, Parlow AF, Gavrilova O, Szalayova I, Mezey E, Wess J 2009 Neuronal M3 muscarinic acetylcholine receptors are essential for somatotroph proliferation and normal somatic growth. Proc Natl Acad Sci USA 106:6398-6403
21. Alba M, Salvatori R 2004 A mouse with targeted ablation of the growth hormone-releasing hormone gene: a new model of isolated growth hormone deficiency. Endocrinology 145:4134-4143
22. Lin SC, Lin CR, Gukovsky I, Lusis AJ, Sawchenko PE, Rosenfeld MG 1993 Molecular basis of the little mouse phenotype and implications for cell type-specific growth. Nature 364:208-213
23. Alba M, Salvatori R 2004 Familial growth hormone deficiency and mutations in the GHRH receptor gene. Vitam Horm 69:209-220
24. Miller SA, Dykes DD, Polesky HF 1988 A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215
25. Walker AH, Najarian D, White DL, Jaffe JF, Kanetsky PA, Rebbeck TR 1999 Collection of genomic DNA by buccal swabs for polymerase chain reaction-based biomarker assays. Environ Health Perspect 107:517-520
26. Yamamoto T, Yamashita N, Kuwabara M, Nakano J, Sugimoto H, Akiyama K, Hirai K, Ishii A, Uehara Y, Ohta K 2002 Mutation screening of the muscarinic m2 and m3 receptor genes in asthmatics, outgrow subjects, and normal controls. Ann Genet 45:109-113
27. Anney RJ, Lotfi-Miri M, Olsson CA, Reid SC, Hemphill SA, Patton GC 2007 Variation in the gene coding for the M5 muscarinic receptor (CHRM5) influences cigarette dose but is not associated with dependence to drugs of addiction: Evidence from a prospective population based cohort study of young adults. BMC Genet 8:46
28. Collins FS, Brooks LD, Chakravarti A 1998 A DNA polymorphism discovery resource for research on human genetic variation. Genome Res 8:1229-1231
29. Iida-Klein A, Guo J, Xie LY, Jüppner H, Potts Jr JT, Kronenberg HM, Bringhurst FR, Abou-Samra AB, Segre GV 1995 Truncation of the carboxyl-terminal region of the rat parathyroid hormone (PTH)/PTH-related peptide receptor enhances PTH stimulation of adenylyl cyclase but not phospholipase C. J Biol Chem 270:8458-8465
30. Swigart P, Cockcroft S 1999 Measurement of inositol (poly)phosphate formation using [3H]inositol labeling protocols in permeabilized cells. Methods Mol Biol 114:165-173
31. Müller EE, Locatelli V, Cocchi D 1999 Neuroendocrine control of growth hormone secretion. Physiol Rev 79:511-607
32. Cooper DN, Youssoufian H 1988 The CpG dinucleotide and human genetic disease. Hum Genet 78:151-155
33. Bonner TI, Buckley NJ, Young AC, Brann MR 1987 Identification of a family of muscarinic acetylcholine receptor genes. Science 237:527-532
34. Kitano T, Liu YH, Ueda S, Saitou N 2004 Human-specific amino acid changes found in 103 protein-coding genes. Mol Biol Evol 21:936-944
35. Lee PH, Hodges PK, Glickman F, Chang KJ 1994 Cloning and expression of a cDNA encoding bovine muscarinic acetylcholine m3 receptor. Biochim Biophys Acta 1223:151-154
36. Casanueva FF, Betti R, Cella SG, Muller EE, Mantegazza P 1983 Effect of agonists and antagonists of cholinergic neurotransmission on growth hormone release in the dog. Acta Endocrinol (Copenh) 103:15-20
37. Yamada M, Miyakawa T, Duttaroy A, Yamanaka A, Moriguchi T, Makita R, Ogawa M, Chou CJ, Xia B, Crawley JN, Felder CC, Deng CX, Wess J 2001 Mice lacking the M3 muscarinic acetylcholine receptor are hypophagic and lean. Nature 410:207-212
38. Ochi M, Tominaga K, Tanaka F, Tanigawa T, Shiba M, Watanabe T, Fujiwara Y, Oshitani N, Higuchi K, Arakawa T 2008 Effect of chronic stress on gastric emptying and plasma ghrelin levels in rats. Life Sci 82:862-868
39. Malik NM, Moore GB, Kaur R, Liu YL, Wood SL, Morrow RW, Sanger GJ, Andrews PL 2008 Adaptive upregulation of gastric and hypothalamic ghrelin receptors and increased plasma ghrelin in a model of cancer chemotherapy-induced dyspepsia. Regul Pept 148:33-38
40. Alba M, Schally AV, Salvatori R 2005 Partial reversibility of GH deficiency in the GHRH knockout mouse by postnatal treatment with a GHRH analog. Endocrinology 146:1506-1513
41. Argyropoulou M, Perignon F, Brunelle F, Brauner R, Rappaport R 1991 Height of normal pituitary gland as a function of age evaluated by magnetic resonance imaging in children. Pediatr Radiol 21:247-249